We just received data on a new analyst forecast for $DRUG. Thomas Shrader from BTIG set a price target of 72.0 for DRUG.
To track analyst ratings and price targets for $DRUG, check out Quiver Quantitative's $DRUG forecast page.
$DRUG Price Targets
Multiple analysts have issued price targets for $DRUG recently. We have seen 3 analysts offer price targets for $DRUG in the last 6 months, with a median target of $80.0.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $72.0 on 09/08/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $85.0 on 08/19/2025
- Rudy Li from Chardan Capital set a target price of $80.0 on 05/21/2025
$DRUG Hedge Fund Activity
We have seen 30 institutional investors add shares of $DRUG stock to their portfolio, and 24 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LOGOS GLOBAL MANAGEMENT LP removed 245,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $8,837,150
- BLACKROCK, INC. added 208,999 shares (+30825.8%) to their portfolio in Q2 2025, for an estimated $5,456,963
- RA CAPITAL MANAGEMENT, L.P. removed 206,427 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $5,389,808
- MILLENNIUM MANAGEMENT LLC removed 81,186 shares (-42.2%) from their portfolio in Q2 2025, for an estimated $2,119,766
- SPRINGHILL FUND ASSET MANAGEMENT (HK) CO LTD removed 60,648 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,187,573
- GEODE CAPITAL MANAGEMENT, LLC added 57,521 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,501,873
- JANUS HENDERSON GROUP PLC added 34,292 shares (+3.1%) to their portfolio in Q2 2025, for an estimated $895,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
